Literature DB >> 12898653

A sensitive and selective liquid chromatographic/electrospray ionization tandem mass spectrometric assay for the simultaneous quantification of alpha-,beta-arteether and its metabolite dihydroartemisinin in plasma, useful for pharmacokinetic studies.

S Sabarinath1, M Rajanikanth, K P Madhusudanan, R C Gupta.   

Abstract

A sensitive, selective, specific and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric assay method was developed and validated for the simultaneous quantitation of alpha-,beta-arteether (alpha-,beta-AE) and its metabolite alpha-dihydroartemisinin (DHA) in monkey plasma using the propyl ether analogue of beta-arteether (PE) as an internal standard. The method involves a simple two-step liquid-liquid extraction with hexane. The analytes were chromatographed on a C(18) reversed-phase chromatographic column by isocratic elution with methanol-ammonium acetate buffer (pH 4) (92 : 8, v/v) and analysed by mass spectrometry in the multiple reaction monitoring mode. The chromatographic run time was 7 min and the weighted (1/x(2)) calibration curves were linear over the range 0.78-200 ng ml(-1). The method was validated in terms of accuracy, precision, absolute recovery, freeze-thaw stability, bench-top stability and re-injection reproducibility. The limit of detection and lower limit of quantification in monkey plasma were 0.39 and 0.78 ng ml(-1) respectively for all the analytes. The intra- and inter-batch precision and accuracy were found to be well within acceptable limits (<15%). All three analytes were stable even after three freeze-thaw cycles (deviation < 15%). The average absolute recoveries of alpha-,beta-AE, DHA and PE, used as an internal standard, from spiked plasma samples were 85.85 +/- 6.56, 70.10 +/- 7.06, 54.37 +/- 3.39 and 93.90 +/- 6.9%, respectively. The assay method described here could be applied to study the pharmacokinetics of alpha-,beta-AE and DHA in rhesus monkeys. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898653     DOI: 10.1002/jms.487

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  4 in total

1.  Clinical pharmacokinetics of the diastereomers of arteether in healthy volunteers.

Authors:  Sreedharan N Sabarinath; Omkar P Asthana; Sunil K Puri; Kumkum Srivastava; Kunnath P Madhusudanan; Ram C Gupta
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.

Authors:  Paktiya Teja-Isavadharm; James O Peggins; Thomas G Brewer; Nicholas J White; H Kyle Webster; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 3.  Stereodynamic investigation of labile stereogenic centres in dihydroartemisinin.

Authors:  Ilaria D'Acquarica; Francesco Gasparrini; Dorina Kotoni; Marco Pierini; Claudio Villani; Walter Cabri; Michela Di Mattia; Fabrizio Giorgi
Journal:  Molecules       Date:  2010-03-05       Impact factor: 4.411

4.  A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies.

Authors:  Nethravathi Puttappa; Karthik Yamjala; Narenderan S T; Suresh Kumar Raman; Gowthamarajan Kuppusamy; Basuvan Babu; P Ram Kumar
Journal:  RSC Adv       Date:  2019-12-17       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.